Executive Management and Board of Directors

CEO

Heidi Tveit

Associate Professor at Department of Molecular Biosciences at University of Oslo, Norway.

More than 20 years of experience in life science, both private and academic sector. Co-founder of Sana Pharma Medical and CEO since 2014.

VP M&A

Anders Larnholt

Founder of Mallax and more than 20 years of pharma and healthcare experience from various executive positions, M&A, strategic advisory and board positions at Meda, Trimb Healthcare and other companies.

Contact details

anders.larnholt@mallaxpharma.com

+46 76 677 6495

CFO

Morten Brennesvik-Jensen

Morten has more than 25 years of experience within finance, M&A and administration within the pharmaceuticals and food supplement business.

Morten has been involved in building up numerous start-up companies and has listed, and de-listed, several companies on the Oslo stock exchange.

Board of directors

Dr Peter Sjöstrand, Chairman of Mallax Pharmaceuticals Holding AB

Former deputy CEO and CFO of Astra and former Chairman of the Boards of Gambro and Meda.

Magnus Edlund

Magnus Edlund is a Partner at Impilo and a Board Member of Mallax Pharmaceuticals AB.


magnus.edlund@impilo.se

Victor Steien

Victor is a Director at Impilo and a Board Member of Mallax Pharmaceuticals Holding AB.

victor.steien@impilo.se

Andres Kongsgaard Flaaten

Andres Kongsgaard Flaaten is owner of Helse As and Board Member of Mallax.


Impilo is majority owner of Mallax

Impilo is a Nordic-based investment company focused on investments in healthcare and the health-related sector. Our starting point is that our portfolio companies must contribute to a positive and sustainable development of the communities and markets in which they operate in order to remain successful in the long term. To find out more, visit www.impilo.se